Both health systems issued news releases announcing the deal, but neither elaborated on what kind of transaction, such as a merger or acquisition, would result. Financial terms of the deal were not disclosed. Geisinger and AtlantiCare executives will now undergo due diligence over the next nine to 12 months to reach a definitive agreement.
AtlantiCare President and CEO David Tilton said in a news release his one-hospital integrated system has been searching for a partner for the past year and ultimately chose Geisinger because it is viewed as a “national model for innovation and value.” Geisinger President and CEO Glenn Steele Jr., MD, PhD, said the transaction will help Geisinger enhance population health initiatives.
Geisinger recently received approved from Pennsylvania state officials to move forward with its acquisition of Lewistown (Pa.) Hospital. Geisinger is also in the process of affiliating with Holy Spirit Health System in Camp Hill, Pa., with a final agreement expected early next year. If the Holy Spirit and AtlantiCare deals go through, Geisinger would have nine acute-care hospitals, a children’s hospital and a heart hospital.
More Articles on Hospital Transactions:
Maimonides, Richmond University Medical Centers Discuss Partnership
Montefiore Finalizes Sound Shore Acquisition
East Jefferson General Hospital Physicians Favor HCA as Lease Partner
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
